{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T20:52:53Z","timestamp":1771966373319,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-01648-7","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T07:31:51Z","timestamp":1743233511000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hepatobiliary phase manifestations of breast cancer liver metastasis: differentiating molecular types through Gd-EOB-DTPA-enhanced MRI"],"prefix":"10.1186","volume":"25","author":[{"given":"Hui","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Rong","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng-Rui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing-Jie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Kai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Na","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"issue":"10","key":"1648_CR1","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.ejso.2012.04.015","volume":"38","author":"GA van Walsum","year":"2012","unstructured":"van Walsum GA, de Ridder JA, Verhoef C, Bosscha K, van Gulik TM, Hesselink EJ, Ruers TJ, van den Tol MP, Nagtegaal ID, Brouwers M, van Hillegersberg R, Porte RJ, Rijken AM, Strobbe LJ, de Wilt JH, Dutch Liver Surgeons Group. Resection of liver metastases in patients with breast cancer: survival and prognostic factors. Eur J Surg Oncol. 2012;38(10):910\u20137. https:\/\/doi.org\/10.1016\/j.ejso.2012.04.015.","journal-title":"Eur J Surg Oncol"},{"issue":"7418","key":"1648_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"Cancer Genome Atlas Network","year":"2012","unstructured":"Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumors. Nature. 2012;490(7418):61\u201370. https:\/\/doi.org\/10.1038\/nature11412.","journal-title":"Nature"},{"issue":"20","key":"1648_CR3","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1200\/JCO.2009.25.9820","volume":"28","author":"H Kennecke","year":"2010","unstructured":"Kennecke H, Yerushalmi R, Woods R, Cheang MC, Voduc D, Speers CH, Nielsen TO, Gelmon K. Metastatic behavior of breast cancer subtypes. J Clin Oncol. 2010;28(20):3271\u20137. https:\/\/doi.org\/10.1200\/JCO.2009.25.9820.","journal-title":"J Clin Oncol"},{"issue":"8","key":"1648_CR4","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.mri.2012.03.007","volume":"30","author":"S Ha","year":"2012","unstructured":"Ha S, Lee CH, Kim BH, Park YS, Lee J, Choi JW, Kim KA, Park CM. Paradoxical uptake of Gd-EOB-DTPA on the hepatobiliary phase in the evaluation of hepatic metastasis from breast cancer: is the target sign a common finding? Magn Reson Imaging. 2012;30(8):1083\u201390. https:\/\/doi.org\/10.1016\/j.mri.2012.03.007.","journal-title":"Magn Reson Imaging"},{"issue":"12","key":"1648_CR5","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1016\/j.ejrad.2012.03.032","volume":"81","author":"A Kim","year":"2012","unstructured":"Kim A, Lee CH, Kim BH, Lee J, Choi JW, Park YS, Kim KA, Park CM. Gadoxetic acid-enhanced 3.0T MRI for the evaluation of hepatic metastasis from colorectal cancer: metastasis is not always seen as a defect in the hepatobiliary phase. Eur J Radiol. 2012;81(12):3998\u20134004. https:\/\/doi.org\/10.1016\/j.ejrad.2012.03.032.","journal-title":"Eur J Radiol"},{"issue":"7","key":"1648_CR6","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1007\/s00261-015-0488-7","volume":"40","author":"V Granata","year":"2015","unstructured":"Granata V, Catalano O, Fusco R, Tatangelo F, Rega D, Nasti G, Avallone A, Piccirillo M, Izzo F, Petrillo A. The target sign in colorectal liver metastases: an atypical Gd-EOB-DTPA uptake on the hepatobiliary phase of MR imaging. Abdom Imaging. 2015;40(7):2364\u201371. https:\/\/doi.org\/10.1007\/s00261-015-0488-7.","journal-title":"Abdom Imaging"},{"key":"1648_CR7","doi-asserted-by":"publisher","unstructured":"Fujita N, Nishie A, Asayama Y, Ishigami K, Ushijima Y, Kakihara D, Nakayama T, Morita K, Ishimatsu K, Honda H. Hyperintense Liver Masses at Hepatobiliary Phase Gadoxetic Acid-enhanced MRI: Imaging Appearances and Clinical Importance. Radiographics. 2020 Jan-Feb;40(1):72\u201394. https:\/\/doi.org\/10.1148\/rg.2020190037","DOI":"10.1148\/rg.2020190037"},{"issue":"Pt 3","key":"1648_CR8","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1042\/BJ20030034","volume":"371","author":"O Briz","year":"2003","unstructured":"Briz O, Serrano MA, MacIas RI, Gonzalez-Gallego J, Marin JJ. Role of organic anion-transporting polypeptides, OATP-A, OATP-C, and OATP-8, in the human placenta-maternal liver tandem excretory pathway for fetal bilirubin. Biochem J. 2003;371(Pt 3):897\u2013905. https:\/\/doi.org\/10.1042\/BJ20030034.","journal-title":"Biochem J"},{"issue":"13","key":"1648_CR9","doi-asserted-by":"publisher","first-page":"9626","DOI":"10.1074\/jbc.M004968200","volume":"276","author":"Y Cui","year":"2001","unstructured":"Cui Y, K\u00f6nig J, Leier I, Buchholz U, Keppler D. Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem. 2001;276(13):9626\u201330. https:\/\/doi.org\/10.1074\/jbc.M004968200.","journal-title":"J Biol Chem"},{"issue":"10","key":"1648_CR10","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1111\/j.1349-7006.2007.00570.x","volume":"98","author":"M Muto","year":"2007","unstructured":"Muto M, Onogawa T, Suzuki T, Ishida T, Akiyama T, Katayose Y, Ohuchi N, Sasano H, Abe T, Unno M. Human liver-specific organic anion transporter-2 is a potent prognostic factor for human breast carcinoma. Cancer Sci. 2007;98(10):1570\u20136. https:\/\/doi.org\/10.1111\/j.1349-7006.2007.00570.x.","journal-title":"Cancer Sci"},{"issue":"Suppl 2","key":"1648_CR11","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.3816\/CBC.2009.s.008","volume":"9","author":"CK Anders","year":"2009","unstructured":"Anders CK, Carey LA. Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer. Clin Breast Cancer. 2009;9(Suppl 2):S73\u201381. https:\/\/doi.org\/10.3816\/CBC.2009.s.008.","journal-title":"Clin Breast Cancer"},{"issue":"9","key":"1648_CR12","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.2741\/3909","volume":"16","author":"CA St Hill","year":"2011","unstructured":"St Hill CA. Interactions between endothelial selectins and cancer cells regulate metastasis. Front Biosci (Landmark Ed). 2011;16(9):3233\u201351. https:\/\/doi.org\/10.2741\/3909.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"19","key":"1648_CR13","first-page":"5393","volume":"62","author":"AM Khatib","year":"2002","unstructured":"Khatib AM, Fallavollita L, Wancewicz EV, Monia BP, Brodt P. Inhibition of hepatic endothelial E-selectin expression by C-raf antisense oligonucleotides blocks colorectal carcinoma liver metastasis. Cancer Res. 2002;62(19):5393\u20138.","journal-title":"Cancer Res"},{"issue":"33","key":"1648_CR14","doi-asserted-by":"publisher","first-page":"11651","DOI":"10.1073\/pnas.0505575102","volume":"102","author":"J Lagani\u00e8re","year":"2005","unstructured":"Lagani\u00e8re J, Deblois G, Lefebvre C, Bataille AR, Robert F, Gigu\u00e8re V. From the cover: location analysis of Estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the Estrogen response. Proc Natl Acad Sci U S A. 2005;102(33):11651\u20136. https:\/\/doi.org\/10.1073\/pnas.0505575102.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3 Suppl","key":"1648_CR15","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.1177\/1066896910370771","volume":"18","author":"SJ Schnitt","year":"2010","unstructured":"Schnitt SJ. Will molecular classification replace traditional breast pathology? Int J Surg Pathol. 2010;18(3 Suppl):S162\u20136. https:\/\/doi.org\/10.1177\/1066896910370771.","journal-title":"Int J Surg Pathol"},{"issue":"2","key":"1648_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/jso.21307","volume":"100","author":"J Zhao","year":"2009","unstructured":"Zhao J, Liu H, Wang M, Gu L, Guo X, Gu F, Fu L. Characteristics and prognosis for molecular breast cancer subtypes in Chinese women. J Surg Oncol. 2009;100(2):89\u201394. https:\/\/doi.org\/10.1002\/jso.21307.","journal-title":"J Surg Oncol"},{"issue":"1","key":"1648_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ijc.2910310104","volume":"31","author":"J Gerdes","year":"1983","unstructured":"Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer. 1983;31(1):13\u201320. https:\/\/doi.org\/10.1002\/ijc.2910310104.","journal-title":"Int J Cancer"},{"issue":"34","key":"1648_CR18","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.1200\/JCO.2008.17.0829","volume":"26","author":"G Viale","year":"2008","unstructured":"Viale G, Giobbie-Hurder A, Regan MM, Coates AS, Mastropasqua MG, Dell\u2019Orto P, et al. Breast international group trial 1\u201398. Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from breast international group trial 1\u201398 comparing adjuvant Tamoxifen with letrozole. J Clin Oncol. 2008;26(34):5569\u201375. https:\/\/doi.org\/10.1200\/JCO.2008.17.0829.","journal-title":"J Clin Oncol"},{"issue":"6","key":"1648_CR19","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ctrv.2011.11.006","volume":"38","author":"E Amir","year":"2012","unstructured":"Amir E, Clemons M, Purdie CA, Miller N, Quinlan P, Geddie W, Coleman RE, Freedman OC, Jordan LB, Thompson AM. Tissue confirmation of disease recurrence in breast cancer patients: pooled analysis of multi-centre, multi-disciplinary prospective studies. Cancer Treat Rev. 2012;38(6):708\u201314. https:\/\/doi.org\/10.1016\/j.ctrv.2011.11.006.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"1648_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s12032-010-9418-2","volume":"28","author":"E Sari","year":"2011","unstructured":"Sari E, Guler G, Hayran M, Gullu I, Altundag K, Ozisik Y. Comparative study of the immunohistochemical detection of hormone receptor status and HER-2 expression in primary and paired recurrent\/metastatic lesions of patients with breast cancer. Med Oncol. 2011;28(1):57\u201363. https:\/\/doi.org\/10.1007\/s12032-010-9418-2.","journal-title":"Med Oncol"},{"issue":"9","key":"1648_CR21","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1200\/JCO.2005.03.0783","volume":"24","author":"M Colleoni","year":"2006","unstructured":"International Breast Cancer Study Group, Colleoni M, Gelber S, Goldhirsch A, Aebi S, Castiglione-Gertsch M, Price KN, Coates AS, Gelber RD. Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: international breast cancer study group trial 13\u201393. J Clin Oncol. 2006;24(9):1332\u201341. https:\/\/doi.org\/10.1200\/JCO.2005.03.0783.","journal-title":"J Clin Oncol"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01648-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-01648-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01648-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T07:32:02Z","timestamp":1743233522000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-01648-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1648"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-01648-7","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"assertion":[{"value":"29 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted with approval from the Ethics Committee of The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital (No. HNCH-HER2-MBC001). This study was conducted in accordance with the declaration of Helsinki. Since this study is retrospective and does no harm to the participants and only reviews the data, informed consent was exempted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"104"}}